Why BioNTech Thrashed the Market on Thursday
With its latest ruling on the biotech’s coronavirus vaccine, the FDA boosts the investment case for the stock.
With its latest ruling on the biotech’s coronavirus vaccine, the FDA boosts the investment case for the stock.
What Is A Value Trap? Q2 2021 hedge fund letters, conferences and more With this week’s Tuesday subscriber request video I will…
AG Mortgage Investment Trust (MITT) exits from its sole remaining legacy commercial investment, Commercial Loan L, and was repaid…
Canada’s main stock index rose for a third day on Thursday as investors moved their focus past major event risks that weighed…
BEAVERTON, Ore.–(BUSINESS WIRE)–NIKE, Inc. (NYSE:NKE) today reported fiscal 2022 financial results for its first quarter ended…
Nike shares dropped in extended trading Thursday after the sneaker giant reported quarterly revenue that missed analysts’ expectations. Its stock
In this article we will take a look at the some of notable stocks rising today. You can skip our detailed analysis of these stocks…
IRVINE, Calif., Sept. 23, 2021 /PRNewswire/ — CalAmp (Nasdaq: CAMP), a connected intelligence company helping businesses and…
FREMONT, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) — Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test…
At its 2021 virtual Investor Day held on September 20, 2021, Nextdoor, Inc. (the “Company”) announced an increase in 2021 revenue…